ID: ALA3645243

Max Phase: Preclinical

Molecular Formula: C32H40F4N6O2

Molecular Weight: 616.70

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1CN(C(=O)N(C[C@@H]2CNC[C@@H]2F)[C@@H](c2nc(-c3cc(F)ccc3F)nn2Cc2cccc(F)c2)C(C)(C)C)C[C@H](C)O1

Standard InChI:  InChI=1S/C32H40F4N6O2/c1-19-15-40(16-20(2)44-19)31(43)41(18-22-13-37-14-27(22)36)28(32(3,4)5)30-38-29(25-12-24(34)9-10-26(25)35)39-42(30)17-21-7-6-8-23(33)11-21/h6-12,19-20,22,27-28,37H,13-18H2,1-5H3/t19-,20+,22-,27-,28-/m0/s1

Standard InChI Key:  NIGJERGZJNCPOP-MQUFBMRISA-N

Associated Targets(Human)

Kinesin-like protein 1 1720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 616.70Molecular Weight (Monoisotopic): 616.3149AlogP: 5.59#Rotatable Bonds: 7
Polar Surface Area: 75.52Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.47CX LogP: 5.85CX LogD: 3.80
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.35Np Likeness Score: -1.22

References

1.  (2013)  Triazole compounds as KSP inhibitors, 

Source

Source(1):